Search

Your search keyword '"Gabor A. Fulop"' showing total 3 results
Start Over Author "Gabor A. Fulop" Journal critical care
3 results on '"Gabor A. Fulop"'

1. Levosimendan therapy does not improve survival of post-resuscitation cardiogenic shock patients

Author

Pál Soós, Gabor A. Fulop, B Merkely, G Szabo, László Gellér, A Apor, György Bárczi, Dávid Becker, and Endre Zima

Subjects
Inotrope, medicine.medical_specialty, Myocardial ischemia, business.industry, Cardiogenic shock, Levosimendan, Critical Care and Intensive Care Medicine, medicine.disease, Calcium sensitizer, Contractility, Internal medicine, Poster Presentation, medicine, Cardiology, Post resuscitation, In patient, business, medicine.drug
Abstract

The calcium sensitizer levosimendan enhances myocardial contractility, which could be advantageous in patients with myocardial ischemia requiring inotropic support.

Published
2009

2. Retrospective study of proarrhythmic effects of levosimendan during the therapy of heart failure

Author

György Bárczi, Levente Molnár, Gabor A. Fulop, Endre Zima, Gábor Szücs, B Merkely, A Soltesz, and Dávid Becker

Subjects
Inotrope, Drug, medicine.medical_specialty, business.industry, media_common.quotation_subject, Retrospective cohort study, Levosimendan, Critical Care and Intensive Care Medicine, medicine.disease, Heart failure, Poster Presentation, Medicine, business, Intensive care medicine, media_common, medicine.drug
Abstract

Levosimendan is a new, effective inodilator agent, which is a new alternate drug beside conventional inotropic drugs in treatment of acute and chronic heart failure. Positive inotropic effects of levosimendan is based on myocardial Ca-sensitising. Few clinical data are available about the occurrence of proarrhythmic effects of levosimendan, particularly administered in parallel with catecholamines.

Published
2007

3. Percutaneous coronary intervention in acute coronary syndrome complicated by states Killip 3 and 4 in 2005

Author

Sz. Tóth, Dávid Becker, A Apor, B Merkely, György Bárczi, László Gellér, Gabor A. Fulop, Anikó Horváth, Levente Molnár, G Szabo, and Endre Zima

Subjects
medicine.medical_specialty, Acute coronary syndrome, business.industry, Unstable angina, medicine.medical_treatment, Percutaneous coronary intervention, Critical Care and Intensive Care Medicine, medicine.disease, surgical procedures, operative, Internal medicine, Conventional PCI, Poster Presentation, medicine, Cardiology, Effective treatment, cardiovascular diseases, Medical emergency, Myocardial infarction, business
Abstract

Early percutaneous coronary intervention (PCI) is the most effective treatment for acute coronary syndrome (ACS, ST-elevation myocardial infarction (STEMI), non-STEMI, unstable angina pectoris) complicated by states Killip 3 and 4.

Published
2007

Catalog

Books, media, physical & digital resources
See catalog results